| INAVOLISIB 
| INAVOLISIB | ANTINEOPLASTIC KINASE INHIBITOR TREATMENT OF METASTATIC BREAST CANCER | ORAL | Cmax 169.3 NANOMOLAR Tmax 3 HOUR F 76 PERCENT VD 155 LITER PPB 37 PERCENT Cl 8.8 LITER / HOUR HT 15 HOUR SOLUBILITY DECREASES WITH INCREASING PH | PHOSPHATIDYLINOSITOL 3-KINASE (PI3K) ALPHA PDB 8EXV (CRYSTAL STRUCTURE OF PI3K-ALPHA IN COMPLEX WITH COMPOUND 32) LIGAND CODE = X3N (link to the list of PDB complexes) Download experimental 3D coordinates of X3N with added hydrogens | - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com VigiAccess SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |